Sign Up to like & get
recommendations!
0
Published in 2017 at "Value in health regional issues"
DOI: 10.1016/j.vhri.2017.02.001
Abstract: Off-patent pharmaceuticals (OPPs) represent more than 60% of the pharmaceutical market in many emerging countries, where they are frequently evaluated primarily on cost rather than with health technology assessment. OPPs are assumed to be identical…
read more here.
Keywords:
decision;
methodology;
simple scoring;
mcda simple ... See more keywords